INmune Bio Newsroom

BTIG Maintains INmune Bio(INMB.US) With Buy Rating, Maintains Target Price $21

Futu NewsNov 1 20:36

Scotiabank Maintains INmune Bio(INMB.US) With Buy Rating, Maintains Target Price $22

Futu NewsNov 1 20:35

A. G. P. Initiates INmune Bio(INMB.US) With Buy Rating, Announces Target Price $20

Futu NewsOct 21 19:31

Scotiabank Maintains INmune Bio(INMB.US) With Buy Rating, Maintains Target Price $22

Futu NewsOct 1 21:31

Inmune Bio (INMB) Receives a Buy From Scotiabank

TipRanksOct 1 21:29

INmune Bio Initiated at Outperform by Raymond James

Dow JonesSep 28 01:22

INmune Bio Analyst Ratings

BenzingaSep 28 01:12

Maxim Group Maintains INmune Bio(INMB.US) With Buy Rating, Maintains Target Price $22

Futu NewsSep 28 00:32

BTIG Maintains INmune Bio(INMB.US) With Buy Rating, Maintains Target Price $21

Futu NewsSep 27 18:31

Buy Rating Affirmed for Inmune Bio on Promising Clinical Data and Market Potential

TipRanksSep 27 18:18

Raymond James Initiates INmune Bio(INMB.US) With Buy Rating, Announces Target Price $18

Futu NewsSep 27 05:31

Maxim Group Maintains INmune Bio(INMB.US) With Buy Rating, Maintains Target Price $22

Futu NewsSep 19 03:31

Scotiabank Maintains INmune Bio(INMB.US) With Buy Rating, Maintains Target Price $22

Futu NewsSep 18 20:31

Analysts Offer Insights on Healthcare Companies: Inmune Bio (INMB) and Zevra Therapeutics (ZVRA)

TipRanksSep 18 19:44

BTIG Maintains INmune Bio(INMB.US) With Buy Rating, Maintains Target Price $21

Futu NewsSep 18 19:34

Inmune Bio's Promising AD Treatment Approach Merits Buy Rating, Analyst Says

TipRanksSep 18 18:50

Scotiabank Initiates Coverage On INmune Bio With Sector Outperform Rating, Announces Price Target of $22

BenzingaAug 22 20:34

INmune Bio Analyst Ratings

BenzingaAug 22 20:33

Scotiabank Initiates INmune Bio(INMB.US) With Buy Rating, Announces Target Price $22

Futu NewsAug 22 04:32

Inmune Bio's Promising Pipeline and Strong Cash Position Merit a Buy Rating

TipRanksAug 5 14:31